1.17
전일 마감가:
$1.23
열려 있는:
$1.24
하루 거래량:
77,758
Relative Volume:
0.05
시가총액:
$2.48M
수익:
$35.49M
순이익/손실:
$-6.04M
주가수익비율:
-0.0899
EPS:
-13.0191
순현금흐름:
$-6.42M
1주 성능:
-29.52%
1개월 성능:
-44.29%
6개월 성능:
-90.41%
1년 성능:
-91.88%
Sunshine Biopharma Inc Stock (SBFM) Company Profile
명칭
Sunshine Biopharma Inc
전화
954-330-0684
주소
333 LAS OLAS WAY, FORT LAUDERDALE
Compare SBFM vs TAK, HLN, TEVA, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
SBFM
Sunshine Biopharma Inc
|
1.17 | 3.25M | 35.49M | -6.04M | -6.42M | -13.02 |
|
TAK
Takeda Pharmaceutical Co Adr
|
17.10 | 55.69B | 29.91B | 1.30B | 3.49B | 0.4056 |
|
HLN
Haleon Plc Adr
|
9.855 | 43.77B | 14.54B | 2.22B | 2.58B | 0.4871 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.01 | 36.19B | 17.53B | 1.58B | 444.18M | 1.3457 |
|
ZTS
Zoetis Inc
|
77.28 | 32.25B | 9.51B | 2.64B | 2.14B | 6.0361 |
|
UTHR
United Therapeutics Corp
|
517.71 | 26.29B | 3.17B | 1.29B | 1.01B | 27.09 |
Sunshine Biopharma Inc 주식(SBFM)의 최신 뉴스
SBFM Looks 79.1% Undervalued on GF Value™ Amid Challenging Finan - GuruFocus
Sunshine Biopharma receives Canadian approval for ondansetron - Investing.com
Health Canada Approves Sunshine Biopharma's Ondansetron for Treatment of Chemotherapy-Induced Nausea and Vomiting - Weatherford Democrat
Sunshine Biopharma Inc (SBFM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
SBFM|Sunshine Biopharma Inc|Price:1.696| - TradingKey
Sunshine Biopharma Inc (SBFM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sunshine Biopharma Inc. Revenue Breakdown – BOATS:SBFMW - TradingView
Sunshine Biopharma Inc (SBFM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Price to sales forward of Sunshine Biopharma Inc. – NASDAQ:SBFMW - TradingView
Sunshine Biopharma Announces ATM Equity Sales Agreement - The Globe and Mail
Sunshine Biopharma plans up to $4 million at-the-market share sale via Aegis Capital - Bitget
Sunshine BiopharmaEnters At-The-Market Sales Agreement With Aegis Capital For Up To $4 MillionSEC Filing - TradingView
Sunshine Biopharma announces publication of new results on MR1-114 - TipRanks
Sunshine Biopharma (SBFM) Reports Breakthrough Research on SARS-CoV-2 Treatment - GuruFocus
Sunshine Biopharma and University of Arizona Publish Significant New Research Findings - The Daily Corinthian
Form DEF 14A Sunshine Biopharma Inc For: 16 July By Investing.com - Investing.com Canada
Sunshine Biopharma (SBFM) Eases 1.5% as Stock Tests Support Near $1.82Market Cap Weight - dars.gov.et
Sunshine Biopharma stock rallies on Canadian approval for generic amoxicillin - MSN
Sunshine Biopharma Settles Dispute With Former Nora President - The Globe and Mail
Sunshine Biopharma (NASDAQ: SBFM) pays CAD$1.5M to settle Nora Pharma dispute - Stock Titan
Sunshine Biopharma (SBFM) Posts Modest Gain Amid Narrow Trading RangeHead and Shoulders - dars.gov.et
Alta Partners LLC reports 200,000 shares in Sunshine Biopharma (SBFM) - Stock Titan
Sunshine Biopharma Company Profile & Introduction - Moomoo
Enterprise value to EBITDA forward of Sunshine Biopharma Inc. – NASDAQ:SBFMW - TradingView
Enterprise value to EBIT forward of Sunshine Biopharma Inc. – NASDAQ:SBFMW - TradingView
Price to earnings forward of Sunshine Biopharma Inc. – NASDAQ:SBFMW - TradingView
Sunshine Biopharma(SBFM) Stock Options Chain | Quotes & News - Moomoo
Sunshine Biopharma (SBFM) Dips 3.2% as Stock Nears Key Support at $2.00IV Rank - dars.gov.et
SBFM Q1 2026 Earnings: Pre-Revenue Biopharma Reports Net Loss Per Share of -$0.25Trough Earnings Signal - DonanımHaber
Sunshine Biopharma (SBFM) Edges Higher Amid Sector Support – Key Levels to WatchCup and Handle - dars.gov.et
Sunshine Biopharma (SBFM) Edges Higher, Nears Resistance at $2.29Island Reversal - dars.gov.et
Sunshine Biopharma Inc. Q1 2026 Earnings: Narrowing Loss Reflects Ongoing Pipeline ProgressCFO Commentary Report - dars.gov.et
Sunshine Biopharma Receives Canadian Regulatory Approval for Generic Arimidex(R) - Black Hills Pioneer
Sunshine Biopharma Inc (SBFM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Sunshine Biopharma receives Canadian approval for generic Arimidex - TipRanks
Price to sales forward of Sunshine Biopharma Inc. – NASDAQ:SBFM - TradingView
SBFM Forecast — Price Target — Prediction for 2027 - TradingView
Number of shareholders of Sunshine Biopharma Inc. – NASDAQ:SBFM - TradingView
Sunshine Biopharma (SBFM) Gains Approval for Generic Anastrozole in Canada - GuruFocus
Sunshine gets Canadian approval for 1mg Anastrozole - grafa.com
Sunshine Biopharma gets Canada approval for generic Arimidex - Stock Titan
SBFM Q1 2026 Earnings: Net Loss of $0.25 per Share as Company Advances Drug PipelineGrowth Acceleration Report - dars.gov.et
Form PRE 14A Sunshine Biopharma Inc For: 22 June By Investing.com - Investing.com Australia
Sunshine Biopharma Inc (SBFMW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Sunshine Biopharma Inc. (SBFM) Q1 2026 Earnings: Negative EPS of -$0.25 Reported; Stock Rises $0.47Profit Margin Analysis - dars.gov.et
SBFM Q1 2026 Earnings: Pre-Revenue Biotech Reports Net Loss as Pipeline AdvancesEarnings Surprise Stocks - dars.gov.et
SBFM News | SUNSHINE BIOPHARMA INC (NASDAQ:SBFM) - ChartMill
Sunshine Biopharma Inc (SBFMW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Sunshine Biopharma Inc (SBFMW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Sunshine Biopharma Inc (SBFMW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Sunshine Biopharma Inc (SBFM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Sunshine Biopharma Inc (SBFM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):